Journals / Infectious diseases and clinical microbiology (Online) / 2022 / Cilt: 4 - Sayı: 1

Predictors of Severity and Mortality in COVID-19: A Retrospective Study from Batman, Turkey

Pages
18–29
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Determining risk factors for COVID-19 severity and mortality are critical for classifying critical cases at the time of initial diagnosis, establishing appropriately specific treatment protocols, and ensuring access to early treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: It is increasingly important to identify risk factors for COVID-19-associated mortality to provide access to early treatment.
📊
Key Findings & Data:This study aimed to investigate the relationship between COVID-19 severity and laboratory data and demographic characteristics of hospitalized patients and to identify factors predicting mortality in COVID-19.
💡
Conclusion & Impact:Determining risk factors for COVID-19 severity and mortality are critical for classifying critical cases at the time of initial diagnosis, establishing appropriately specific treatment protocols, and ensuring access to early treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: It is increasingly important to identify risk factors for COVID-19-associated mortality to provide access to early treatment. This study aimed to investigate the relationship between COVID-19 severity and laboratory data and demographic characteristics of hospitalized patients and to identify factors predicting mortality in COVID-19. Materials and Methods: The study is a retrospective and single-center study. Data of 1298 COVID-19 patients confirmed by a positive real-time polymerase chain reaction test for COVID-19 and treated at the hospital were retrospectively analyzed. Study patients were divided into three groups based on the clinical severity of disease: the mild-moderate group (n:954) and the severe (n:310) and critical (n:34) groups. Demographic characteristics, underlying diseases, and laboratory findings were compared between groups. Results: Multivariate logistic and ordinal logistic regression analysis revealed that male gender, old age, diabetes mellitus, coronary artery disease, cerebrovascular event, malignancy, chronic obstructive pulmonary disease, chronic renal failure, chronic hepatitis B, and Alzheimer’s disease/dementia/Parkinson’s disease (among neurological diseases) were independently associated with and significantly increased the development of severe disease and mortality. Conclusion: The COVID-19 pandemic continues to be a significant health problem affecting all of humanity. Determining risk factors for COVID-19 severity and mortality are critical for classifying critical cases at the time of initial diagnosis, establishing appropriately specific treatment protocols, and ensuring access to early treatment.

🔖

Cite This Article

AKGÜL, F., SEVİM, B., ARSLAN, Y., ŞENCAN, M., ATABEY, P., AKTAŞ, A. (2022). Predictors of Severity and Mortality in COVID-19: A Retrospective Study from Batman, Turkey. Infectious diseases and clinical microbiology (Online), Cilt: 4 - Sayı: 1, 18–29. https://ajindex.com/articles/539045

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. 1 Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020
  2. 395(10223):497-506. [CrossRef] 2 Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020
  3. 382(8):727-33. [CrossRef] 3 Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. J Med Virol. 2020
  4. 92(10):1733-4. [CrossRef] 4 Clinical Management of COVID-19 [Internet]. (Cited November 17, 2021). Available from: https://www.who.int/publications/i/item/clinical-management-of-covid-19. 5 Günal Ö, Türe E, Bayburtlu M, Arslan U, Demirağ MD, Taşkın MH, et al. COVID-19 tanılı hastaların risk faktörleri açısından değerlendirilmesi. Mikrobiyol Bul. 2020
  5. 54(4):575-82. [CrossRef] 6 Wenham C, Smith J, Morgan R
  6. Gender and COVID-19 Working Group. COVID-19: the gendered impacts of the outbreak. Lancet. 2020
  7. 395(10227):846-8. [CrossRef] 7 Izcovich A, Ragusa M, Sanguine V, Tortosa F, Espinosa F, Agnoletti C, et al. Prognostic factors for severity and mortality in patients infected with COVID-19: a living systematic review protocol. medRxiv. 2020
  8. 15(11):e0241955. https://doi.org/10.1371/ journal.pone.0241955 8 Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection. 2021
  9. 49(1):15-28. [CrossRef] 9 Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al. Gender differences in patients with COVID-19: Focus on severity and mortality. Front Public Health. 2020
  10. [CrossRef] 10 Kragholm K, Andersen MP, Gerds TA, Butt JH, Østergaard L, Polcwiartek C, et al. Association between male sex and outcomes of coronavirus disease 2019 (COVID-19)–A Danish nationwide, register-based study. Clin Infect Dis. 2021
  11. 73(11):e4025-30. [CrossRef] 11 Mughal MS, Kaur IP, Jaffery AR, Dalmacion DL, Wang C, Koyoda S, et al. COVID-19 patients in a tertiary US hospital: Assessment of clinical course and predictors of the disease severity. Respir Med. 2020
  12. 106130. [CrossRef] 12 Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020
  13. 146(1):110-8. [CrossRef] 13 Du H, Dong X, Zhang J, Cao Y, Akdis M, Huang P, et al. Clinical characteristics of 182 pediatric COVID-19 patients with different severiti